EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer

Hung-Hsun Chen, Shu-Jyuan Chang iD, Jung-Yu Kan, Fang-Ming Chen, Chung-Liang Li, Hidenobu Takahashi iD, Shen-Liang Shih, Ming-Feng Hou, Mei-Ren Pan, Ping-Fu Yang, Chi-Wen Luo iD

Breast Cancer: Targets and Therapy · 2026-04 · Volume 18 · 1-13

DOI: 10.2147/bctt.s597707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-04. Verfasst von Hung-Hsun Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwa…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Ki-67PRbreast cancerchemotherapyrisk stratification

Autor:innen und Institutionen

  • Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Gangshan Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.

ORCID-Profile: Shu-Jyuan Chang, Hidenobu Takahashi, Chi-Wen Luo

Zitieren

APA

Chen, H. H., Chang, S. J., Kan, J. Y., Chen, F. M., Li, C. L., Takahashi, H., Shih, S. L., Hou, M. F., Pan, M. R., Yang, P. F., & Luo, C. W. (2026). Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer. Breast Cancer: Targets and Therapy, Volume 18, 1-13. https://doi.org/10.2147/bctt.s597707

Vancouver

Chen HH, Chang SJ, Kan JY, Chen FM, Li CL, Takahashi H, et al. Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-13. doi:10.2147/bctt.s597707

BibTeX
@article{Chen2026,
  author = {Chen, Hung-Hsun and Chang, Shu-Jyuan and Kan, Jung-Yu and Chen, Fang-Ming and Li, Chung-Liang and Takahashi, Hidenobu and Shih, Shen-Liang and Hou, Ming-Feng and Pan, Mei-Ren and Yang, Ping-Fu and Luo, Chi-Wen},
  title = {Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--13},
  doi = {10.2147/bctt.s597707}
}
Kostenlos starten →